Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Non-muscle Invasive Bladder Cancer

Birmingham Alabama 35294

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Homewood Alabama 35209

Patients are needed to participate in a clinical research study of Vicinium to evaluate Bladder Cancer

Alaska

UPDATED

Anchorage Alaska 99503

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

Arizona

UPDATED

Phoenix Arizona 85032

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

UPDATED

Tucson Arizona 85711

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Arkansas

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

California

UPDATED

Los Angeles California CA 90033

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

UPDATED

Los Angeles California 90048

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of CM-24

View More ▼

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

UPDATED

Sacramento California 95817

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

UPDATED

San Francisco California 94158

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

UPDATED

Sherman Oaks California 91411

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

UPDATED

Torrance California 90505

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Duarte California 91010-3000

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

Duarte California 91010

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Fullerton California 92835

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

La Jolla California 92093-0658

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

La Jolla California 92093

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Lancaster California 93534

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Los Angeles California 90024

A clinical research study of [124I] PSCA-Minibody PET/CT imaging of the whole body for the treatment of Prostate Cancer, Pancreatic Cancer or Bladder Cancer

Los Angeles California 90033

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90095

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Los Angeles California

Patients are needed to participate in a clinical research study of Decipher Prostate Cancer Classifier and Decipher Genomics Resource Information Database (GRID) to evaluate Prostate Cancer or Bladder Cancer

Los Angeles California 90033

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Los Angeles California 90024

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

Redondo Beach California 90277

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Sacramento California 95817

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

San Francisco California 94158

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Santa Monica California 93454

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Sherman Oaks California 91411

Patients are needed to participate in a clinical research study of Vicinium to evaluate Bladder Cancer

Stanford California 94305

A clinical trial seeking patients for a research study of Pazopanib (GW786034) and Paclitaxel

Torrance California 90505

Patients are needed to participate in a clinical research study of Vicinium to evaluate Bladder Cancer

Colorado

The Urology Center of Colorado
Denver Colorado 80211

A Phase 1/2a, placebo controlled, randomized study to evaluate the safety, immune response and clinical activity of HS-410 in patients with high risk superficial bladder cancer who have undergone Transurethral Resection of Bladder (TURBT) and received prior treatment with induction of Bacillus Calmette-Guerin (BCG).

View More ▼

UPDATED

Aurora Colorado 80012

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

UPDATED

Denver Colorado 80211

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132